Impax Laboratories Down 6.5% Since Goldman Sachs Upgraded One Week Ago (IPXL)

Impax Laboratories was upgraded from Sell to Neutral by Goldman Sachs one week ago. The stock closed at $24.00, which is 6.5% lower than the price one week ago...